Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease (2019) Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P Journal article, Review article Impact of a clinical decision support tool on prediction of progression in early-stage dementia: A prospective validation study (2019) Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, et al. Journal article Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease (2019) Baldeiras I, Santana I, Leitao MJ, Vieira D, Duro D, Mroczko B, Kornhuber J, Lewczuk P Journal article White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) Teunissen CE, Otto M, Engelborghs S, Herukka SK, Lehmann S, Lewczuk P, Lleo A, et al. Journal article Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease (2018) Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, et al. Journal article Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease (2018) Lewczuk P, Gaignaux A, Kofanova O, Ermann N, Betsou F, Brandner S, Mroczko B, et al. Journal article A language-based sum score for the course and therapeutic intervention in primary progressive aphasia (2018) Semler E, Anderl-Straub S, Uttner I, Diehl-Schmid J, Danek A, Einsiedler B, Fassbender K, et al. Journal article